3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid

C17H18N4O3 — CID 91058422

IUPAC3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid
SMILESO=C(O)C=C[C@@H]1CCC[C@H](n2c(=O)[nH]c3cnc4[nH]ccc4c32)C1
InChIInChI=1S/C17H18N4O3/c22-14(23)5-4-10-2-1-3-11(8-10)21-15-12-6-7-18-16(12)19-9-13(15)20-17(21)24/h4-7,9-11H,1-3,8H2,(H,18,19)(H,20,24)(H,22,23)/t10-,11-/m0/s1
InChIKeyBEQNZULUABWANB-QWRGUYRKSA-N
MW326.36 g/mol
LogP2.58
Rot. Bonds3

About 3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid

3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid (PubChem CID 91058422) has the molecular formula C17H18N4O3 and a molecular weight of 326.36 g/mol. Its IUPAC name is 3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid.

Molecular Properties

Compound Name3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid
PubChem CID91058422
Molecular FormulaC17H18N4O3
Molecular Weight326.36 g/mol
Exact Mass326.14
IUPAC Name3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid
SMILESO=C(O)C=C[C@@H]1CCC[C@H](n2c(=O)[nH]c3cnc4[nH]ccc4c32)C1
InChIInChI=1S/C17H18N4O3/c22-14(23)5-4-10-2-1-3-11(8-10)21-15-12-6-7-18-16(12)19-9-13(15)20-17(21)24/h4-7,9-11H,1-3,8H2,(H,18,19)(H,20,24)(H,22,23)/t10-,11-/m0/s1
InChIKeyBEQNZULUABWANB-QWRGUYRKSA-N
XLogP2.58
TPSA103.77 Ų
H-Bond Donors3
H-Bond Acceptors4
Rotatable Bonds3
Heavy Atoms24
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500326.36
LogP ≤ 52.58
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid?
The IUPAC name of 3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid (CID 91058422) is 3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid.
What is the SMILES notation for 3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid?
The canonical SMILES for 3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid is O=C(O)C=C[C@@H]1CCC[C@H](n2c(=O)[nH]c3cnc4[nH]ccc4c32)C1.
What is the InChIKey of 3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid?
The InChIKey is BEQNZULUABWANB-QWRGUYRKSA-N. The full InChI is InChI=1S/C17H18N4O3/c22-14(23)5-4-10-2-1-3-11(8-10)21-15-12-6-7-18-16(12)19-9-13(15)20-17(21)24/h4-7,9-11H,1-3,8H2,(H,18,19)(H,20,24)(H,22,23)/t10-,11-/m0/s1.
What are the key properties of 3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid?
3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid has a molecular weight of 326.36 g/mol, XLogP of 2.58, 3 rotatable bonds, 3 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(1R,3S)-3-(4-oxo-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,6,8,11-tetraen-3-yl)cyclohexyl]prop-2-enoic acid is sourced from PubChem (CID 91058422), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).